Colonic release food supply as a coadjuvant in the treatment and prevention of colonic disorders caused by a suspected or confirmed alteration of the inflammatory pattern and microbiota destabilization
AssigneeChristalfarma S.R.L.
InventorsMaria Cristina Del Bono, Francesco Bonomo
Life of this patent
Estimating the term…
Abstract
Oral tablet comprising as active principle an association of dry extracts of turmeric, pomegranate and Boswellia, with colonic release, wherein said release is guaranteed by the presence of a combination of sodium alginate and hydroxypropyl methylcellulose in the relative matrix in which the aforementioned active ingredients are dispersed. This oral tablet, preferably in the form of a food supplement, is employed as co-adjuvant in the treatment and prevention of colonic disorders caused by suspected or confirmed alteration of the inflammatory situation and destabilization of the microbiota.
Claims13
A colonic release oral tablet comprising as active ingredients a mixture of dry extracts of turmeric, pomegranate and Boswellia, said active ingredients being dispersed in a matrix together with a combination of sodium alginate and hydroxypropylmethylcellulose wherein said colonic release is guaranteed by said combination of sodium alginate and hydroxypropyl methylcellulose being present in the matrix in which the active ingredients are dispersed, in weight ratios comprised between 1:25 and 1:10.
Dependencies are inferred from the claim text.